The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, 
but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

Rammes, G.; Mahal, B.; Putzke, J.; Parsons, C.; Spielmanns, P.; Pestel, E.; Spanagel, R.; Zieglgänsberger, W.; Schadrack, J.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

MPS-Authors

/persons/resource/persons80484

Rammes, G.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80605

Zieglgänsberger, W.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Rammes, G., Mahal, B., Putzke, J., Parsons, C., Spielmanns, P., Pestel, E., et al. (2001). The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology, 40, 749-760.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-A426-1

Abstract

There is no abstract available